E. YAŞAR Et Al. , "Comparison of homologous and heterologous inactivated and mRNA vaccination programme against SARS-CoV-2 in dialysis patients," Nephrology , vol.29, no.7, pp.405-414, 2024
YAŞAR, E. Et Al. 2024. Comparison of homologous and heterologous inactivated and mRNA vaccination programme against SARS-CoV-2 in dialysis patients. Nephrology , vol.29, no.7 , 405-414.
YAŞAR, E., YILDIZ, Y., ÖZTÜRK, E., Gok Oguz, E., Coskun Yenigun, E., Ozturk, R., ... HELVACI, Ö.(2024). Comparison of homologous and heterologous inactivated and mRNA vaccination programme against SARS-CoV-2 in dialysis patients. Nephrology , vol.29, no.7, 405-414.
YAŞAR, EMRE Et Al. "Comparison of homologous and heterologous inactivated and mRNA vaccination programme against SARS-CoV-2 in dialysis patients," Nephrology , vol.29, no.7, 405-414, 2024
YAŞAR, EMRE Et Al. "Comparison of homologous and heterologous inactivated and mRNA vaccination programme against SARS-CoV-2 in dialysis patients." Nephrology , vol.29, no.7, pp.405-414, 2024
YAŞAR, E. Et Al. (2024) . "Comparison of homologous and heterologous inactivated and mRNA vaccination programme against SARS-CoV-2 in dialysis patients." Nephrology , vol.29, no.7, pp.405-414.
@article{article, author={EMRE YAŞAR Et Al. }, title={Comparison of homologous and heterologous inactivated and mRNA vaccination programme against SARS-CoV-2 in dialysis patients}, journal={Nephrology}, year=2024, pages={405-414} }